
    
      This is a study to evaluate the safety, feasibility and efficacy of BCMA CAR-T in the
      treatment of relapsed or refractory multiple myeloma.

      The Main research objectives:

      To evaluate the safety and efficacy of BCMA CAR-T in patients with relapsed or refractory
      multiple myeloma

      The Secondary research objectives:

      To investigate the cytokinetic characteristics of BCMA CAR-T in patients with relapsed or
      refractory multiple myeloma.
    
  